It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications, and given as a once-a-week subcutaneous injectable
For example, 2 drugs based on the molecule tirzepatide, Mounjaro for diabetes and Zepbound for obesity, work by targeting both GLP-1 receptors and another incretin hormone known as gastric inhibitory polypeptide or GIP
Its triple receptor mechanism also offers broader metabolic benefits, including improved liver health and higher resting energy expenditure
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared either component peptide, or the blend formulation, as a drug for human or veterinary use
For example, patients who take Sermorelin experience more hunger compared to those who use CJC/Ipamorelin